Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab

NCT03480438

Conditions
B-precursor ALL, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany
  • Uniklinik RWTH Aachen Aachen, Germany
  • Charité - Campus Benjamin Franklin Berlin, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
View all 21 locations
View Trial Details
Completed

A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma

NCT01650701

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Nepean Hospital Penrith, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • CHU Mont-Godinne Yvoir, Belgium
View all 35 locations
View Trial Details
Completed

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389

NCT06812780

Conditions
Digestive System Diseases, Fibrosis, Hemic and Lymphatic Diseases, +14 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Rialto, California, United States
  • Research Site Miami Lakes, Florida, United States
  • Research Site Orlando, Florida, United States
View Trial Details
Completed

A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma

NCT05442554

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Huashan Hospital, Fudan University Shanghai, Shanghai Municipality, China
  • West China Hospital, Sichuan University Chengdu, Sichuan, China
View Trial Details
Completed

A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

NCT02500407

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Sansum Medical Clinic, Inc. Santa Barbara, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
View all 35 locations
View Trial Details

Related conditions